Pattern and distribution of myocardial fibrosis in systemic sclerosis - A delayed enhanced magnetic resonance imaging study

被引:167
|
作者
Tzelepis, George E.
Kelekis, Nikolaos L.
Plastiras, Sotiris C.
Mitseas, Panayiotis
Economopoulos, Nikolaos
Kampolis, Christos
Gialafos, Elias J.
Moyssakis, Ioannis
Moutsopoulos, Haralampos M.
机构
[1] Univ Athens, Sch Med, Dept Pathophysiol, GR-11527 Athens, Greece
[2] Univ Athens, Med Sch & Laiko, Athens, Greece
来源
ARTHRITIS AND RHEUMATISM | 2007年 / 56卷 / 11期
关键词
D O I
10.1002/art.22971
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To assess the prevalence and pattern of myocardial fibrosis as detected by delayed enhanced magnetic resonance imaging (DE-MRI) in patients with systemic sclerosis (SSc), and to evaluate a possible association between myocardial fibrosis and cardiac arrhythmias. Methods. Forty-one patients with SSc underwent 24-hour Holter monitoring, Doppler echocardiography, and DE-MRI following gadolinium administration. Results. Technically acceptable DE-MRIs were obtained in 36 patients with SSc. Enhancement on DE-MRI, consistent with myocardial fibrosis, was observed in 24 of these patients (66%), and it was invariably midwall with a linear pattern, mostly involving basal and midcavity segments of the left ventricle. The volume of enhancement (total volume percentage index [TVPI]) did not differ between patients with diffuse SSc and those with limited SSc- (mean +/- SD 1.46 +/- 1.73% versus 1.44 +/- 1.77%; P = 0.98). Patients with a long duration ( >= 15 years) of Raynaud's phenomenon had a greater number of enhancing segments (mean +/- SD 6.55 +/- 4.93 versus 2.96 +/- 3.46; P = 0.017) and a greater TVPI (mean +/- SD 2.44 +/- 1.97% versus 1.02 +/- 1.43%; P = 0.02) than those with a duration of Raynaud's phenomenon <15 years. Nineteen patients with SSc (53%) had abnormal Holler study results. Compared with patients with normal Holter study results, those with abnormal results had a greater number of enhancing segments (mean SD 5.4 +/- 4.8 versus 2.5 +/- 2.9; P < 0.05) and a greater TVPI (mean +/- SD 2.1 +/- 1.9% versus 0.8 +/- 1.2%; P < 0.05). Conclusion. DE-MRI can identify myocardial fibrosis in a significant percentage of patients with SSc and may be a useful noninvasive tool for determining cardiac involvement.
引用
收藏
页码:3827 / 3836
页数:10
相关论文
共 50 条
  • [31] T1 mapping cardiac magnetic resonance imaging frequently detects subclinical diffuse myocardial fibrosis in systemic sclerosis patients
    Poindron, Vincent
    Chatelus, Emmanuel
    Canuet, Matthieu
    Gottenberg, Jacques-Eric
    Arnaud, Laurent
    Gangi, Afshin
    Gavand, Pierre-Edouard
    Guffroy, Aurelien
    Korganow, Anne-Sophie
    Germain, Philippe
    Sibilia, Jean
    El Ghannudi, Soraya
    Martin, Thierry
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2020, 50 (01) : 128 - 134
  • [32] Cardiovascular Magnetic Resonance Imaging of Myocardial Fibrosis in Dermatomyositis
    Arnold, Christiane
    Abdel-Aty, Hassan
    Tillmanns, Christoph
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (05) : 1056 - 1056
  • [33] Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy
    Wilson, JM
    Villareal, RP
    Hariharan, R
    Massumi, A
    Muthupillai, R
    Flamm, SD
    TEXAS HEART INSTITUTE JOURNAL, 2002, 29 (03): : 176 - 180
  • [34] Magnetic resonance imaging for the detection of myocardial fibrosis in scleroderma
    Plastiras, SC
    Kelekis, N
    Tzelepis, GE
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (20): : 2194 - 2196
  • [35] Myocardial fibrosis in a patient with apical hypertrophic cardiomyopathy detected by delayed-enhanced maxgnetic resonance imaging
    Sato, Yuichi
    Matsumoto, Naoya
    Kunimasa, Taeko
    Matsuo, Shinro
    Yoda, Shunichi
    Tani, Shigemasa
    Kunimoto, Satoshi
    Saito, Satoshi
    Hirayama, Atsushi
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 131 (01) : E41 - E43
  • [36] Analysis of the masseter muscle in patients with systemic sclerosis: a study by magnetic resonance imaging
    Marcucci, M.
    Abdala, N.
    DENTOMAXILLOFACIAL RADIOLOGY, 2009, 38 (08) : 524 - 530
  • [37] Magnetic resonance imaging assessment of myocardial drug distribution pattern following intrapericardial administration
    Gleason, JD
    Nguyen, KP
    Kissinger, KV
    Manning, WJ
    Verrier, RL
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 7A - 7A
  • [38] Myocardial delayed enhanced MRI detects atypical pattern of myocardial fibrosis in Chagas' disease
    Rochitte, CE
    Oliveira, PF
    Andrade, JM
    Parga, JR
    Avila, LF
    Castro, CC
    Piva, RM
    Kalil, R
    Cerri, GG
    Ramires, JAF
    CIRCULATION, 2002, 106 (19) : 653 - 653
  • [39] Clinical and laboratory predictions of myocardial inflammation as detected by cardiac magnetic resonance imaging in patients with systemic sclerosis: A pilot study
    Tipparot, Thapanee
    Foocharoen, Chingching
    Mahakkanukrauh, Ajanee
    Suwannaroj, Siraphop
    Nanagara, Ratanavadee
    Pussadhamma, Burabha
    Chaosuwannakit, Narumol
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (12) : 2125 - 2133
  • [40] Bosentan increases myocardial perfusion and function in systemic sclerosis: A magnetic resonance imaging and Tissue-Doppler echography study
    Allanore, Yannick
    Meune, Christophe
    Vignaux, Olivier
    Weber, Simon
    Legmann, Paul
    Kahan, Andre
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (12) : 2464 - 2469